Metabolomic evaluation of urine and liver was conducted to assess the biochemical changes that occur as a result of alcohol-induced liver injury. Male C57BL/6J mice were fed an isocaloric control-or alcoholcontaining liquid diet with 35% of calories from corn oil, 18% protein and 47% carbohydrate/alcohol for up to 36 days ad libitum. Alcohol treatment was initiated at 7 g/kg/day and gradually reached a final dose of 21 g/kg/day. Urine samples were collected at 22, 30 and 36 days and, in additional treatment groups, liver and serum samples were harvested at 28 days. Steatohepatitis was induced in the alcohol-fed group since a 5-fold increase in serum alanine aminotransferase activity, a 6-fold increase in liver injury score (necrosis, inflammation and steatosis) and an increase in lipid peroxidation in liver were observed. Liver and urine samples were analyzed by nuclear magnetic resonance spectroscopy and electrospray infusion/Fourier transform ion cyclotron resonance-mass spectrometry. In livers of alcohol-treated mice the following changes were noted. Hypoxia and glycolysis were activated as evidenced by elevated levels of alanine and lactate. Tyrosine, which is required for L-DOPA and dopamine as well as thyroid hormones, was elevated possibly reflecting alterations of basal metabolism by alcohol. A 4-fold increase in the prostacyclin inhibitor 7,10,13,16-docosatetraenoic acid, a molecule important for regulation of platelet formation and blood clotting, may explain why chronic drinking causes serious bleeding problems. Metabolomic analysis of the urine revealed that alcohol treatment leads to decreased excretion of taurine, a metabolite of glutathione, and an increase in lactate, n-acetylglutamine and n-acetylglycine. Changes in the latter two metabolites suggest an inhibition of the kidney enzyme aminoacylase I and may be useful as markers for alcohol consumption.
Introduction
In North America, liver disease due to alcohol consumption is an important cause of death in adults, although its pathogenesis remains largely unknown. The disease process is characterized by early steatosis, inflammation, and necrosis (often called alcoholic steatohepatitis). In some individuals who abuse alcoholic beverages, liver disease progresses to fibrosis and cirrhosis, which significantly impairs liver function, and can ultimately lead to the development of hepatocellular carcinoma (Purohit et al., 2005; Purohit and Brenner, 2006) .
Much has been learned about the molecular mechanisms of liver damage by alcohol from experiments in model organisms, especially rats and knockout mice (Thurman, 1998) . The Lieber-DeCarli liquid diets contain carbohydrates (11% of calories), protein (18%), fat (35%), and alcohol or maltose dextrin (36%) (Lieber and DeCarli, 1982) . The diet is administered to animals ad libitum and, together with its lowfat and high-protein modifications, is readily available commercially which makes this model easy to use. While animals on Lieber-DeCarli diets have circulating blood alcohol levels around 200 mg/dl after as early as one week of feeding (Sibley and Jerrells, 2000) and liver steatosis develops, the injury has not been reported to progress much farther in mice. Thus, the Lieber-DeCarli model provides only a limited resource for studies of alcohol-related liver disease.
The continuous intragastric enteral alcohol feeding protocol in the rat, known as Tsukamoto-French model (Tsukamoto et al., 1984) , was a major development in alcohol-induced liver injury research. Although this method requires animal surgery and is very labor intensive, it produces liver injury that is consistent with the human disease starting with steatosis, progressing to steatohepatitis and achieving fibrosis after 3 months of exposure in the rat (Tsukamoto et al., 1990) . This force-feeding (through an intragastric cannula) protocol was also adapted to the mouse which allowed mechanistic studies in genetically engineered animals Yin et al., 1999) . Interestingly, alcohol must be delivered in a high-fat corn oil- Toxicology and Applied Pharmacology 232 (2008) 
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Toxicology and Applied Pharmacology j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / y t a a p based diet in order to facilitate the progression of the liver injury in rodents (Nanji et al., 1989) . Recent studies have also implicated fish oil as a source of potentiation of injury in female as compared to males rats using a liquid diet which is formulated similarly to the enteral model . The advantages of the enteral model over liquid diet models include continuous delivery of alcohol 24 h a day which simulates binge drinking, robustness of the liver injury phenotype, and a characteristic cycling in urine alcohol concentrations due to diurnal variation in basal metabolism and hormones. The criticisms of the Tsukamoto-French model have been that it is labor intensive, does not follow a normal nocturnal feeding pattern for rodents, and that the diet is not nutritionally adequate for induction of cytochrome P450 to the same extent as a standard Lieber-DeCarli liquid diet (Ronis et al., 1991) , although it has been reported recently that P450s are well induced in mice and rats after enteral alcohol treatment (Isayama et al., 2003; Bradford et al., 2005) . Because the "success" of each model is assessed largely by its effectiveness to produce liver damage as the key endpoint, the development of an easy-to-use model that produces significant liver injury is desired.
Recently, it was shown that by feeding rats a high-fat corn oilbased modified Lieber-DeCarli diet, together with daily administration of a large dose of alcohol by gavage, produced liver injury similar to that shown by the Tsukamoto-French model after 8 weeks of treatment (Enomoto et al., 1999) . Similar experiments were not successful in the mouse (N. Enomoto, personal communication), possibly due to the stress of daily gavage. Thus, this study was conducted to determine if by using corn oil as the source of fat in the standard Lieber-DeCarli liquid diet it is possible to achieve a liver injury phenotype more similar to human disease. We show that this protocol results in the development of steatohepatitis comparable to that in the Tsukamoto-French model. Furthermore, we utilized metabolomic analysis of the urine and liver extracts to assess the biochemical and molecular changes of the disease progression toward alcohol-induced liver injury.
Materials and methods
Animals and treatments. Male C57Bl/6J mice 6 to 8 weeks of age were fed ad libitum a modified Lieber-DeCarli liquid diet (Cat #710270; Dyets, Inc,"; Bethlehem, PA) for up to 36 days. The diet contained 35% of calories from fat (corn oil), 12% from carbohydrate, 18% from protein, and 35% from ethyl alcohol (alcohol group) or isocaloric maltose dextrin (control group). Alcohol-containing diet was diluted with control diet to gradually increase acclimation to alcohol. Alcohol treatment was initiated with a dose of 7 g/kg/day and gradually increased to 21 g/kg/ day by day 13. Urine was collected on days 22, 30 and 36 by housing mice in individual metabolic cages for 24 h. Separate groups of mice were treated in an identical manner and animals were euthanized at 28 days for collection of serum and liver. Sections of liver were evaluated for several histological indices. Scoring of liver injury was performed using the method developed by Nanji et al.( 1989) . Additional liver sections were stained with Oil Red O and PAS reagent, which are specific for fat and glycogen, respectively, and were quantified using image analysis software (BioQuant Image Analysis, Nashville, TN). Staining for 4-hydroxynonenal was performed using a 1:500 dilution of anti-4HNE antibody (Alpha Diagnostics, San Antonio, TX; HNE11-S) for 1 h and counterstained using the DAKO Envision System-HRP (DAKO Carpinteria, CA";; K1392) following blocking of nonspecific binding with 1:10 dilution of normal goat serum for 30 min. Serum samples were analyzed colorimetrically for a common marker of liver injury alanine aminotransferase (ALT) and urine for creatinine levels. Urine osmolarity was determined using an osmometer (model 5004, Precision Systems, Natick, MA). Urine samples were analyzed by nuclear magnetic resonance (NMR) and liver by NMR and electrospray infusion/Fourier transform ion cyclotron resonance-mass spectrometry (ESI/FITCR-MS).
Liver extraction and analysis by ESI/FTICR-MS and NMR.
A 50-mg sample of frozen liver from each mouse was homogenized in 500 μl of dH 2 O using a TissueLyser (Qiagen, Valencia, CA) for 5 min at 25 Hz. Next, 100 μl of tissue homogenate was added to 100 μl dH 2 O and 1000 μl methanol, which was vortexed then sonicated in icy water for 1 min x 3. The samples were placed at−20°C for at least 2 h followed by centrifugation at 12,000 rpm at 4°C for 10 min. An aliquot of 600 μl of the supernatants were transferred to a 2-ml tube and 400 μl dH 2 O and 500 μl chloroform was added and vortexed. The samples were cooled to-20°C for 2 h and centrifuged at 5000 rpm for 15 min 4°C to separate an upper (aqueous) phase and a lower (organic) phase and 800 μl of the upper phase and 400 μl of the lower phase were carefully transferred to two respective 1.5-ml tubes.
The organic phase was dried and reconstituted in 800 μl 80% methanol and were spiked with 200 μl of internal standard solution (haloperidol 0.2 μg/ml, verapamil 0.1 μg/ml and reserpine 0.1 μg/ml, freshly made in methanol/dH 2 O, 80:20, v/v) . Samples were acidified using 0.1% formic acid and then directly infused into a Bruker 12-Tesla FTICR-MS instrument (Bruker, Bellicia, MA) in positive electrospray ionization (ESI) mode at a flow rate of 2 μl/min. Duplicate mass spectra were acquired within 100 to 900 m/z using a total of accumulation time of 0.5 s, 100 scans per mass spectrum in approximately 3 min.
The liver extracts from the aqueous phase were dried down using a speed-vac and re-suspended in 7 μl of d 2 O containing 5 mM trimethylsilylpropionate (TSP). The liver extracts were analyzed on the Varian Inova 400 MHz NMR using a 5-μl CapNMR probe (Protasis Magnetic Resonance Microsensors, Urbana-Champaign, IL). The sample was introduced into the probe using manual syringe injection connected to capillary tubing. The spectra were acquired with 256 transients with a sweep width of 5000 Hz. The pulse sequence included a 500-ms solvent pre-saturation period, 45°excitation pulse and a 3.3 s acquisition time.
Urine analysis by NMR. Frozen urine samples were allowed to thaw at room temperature. Aliquots of 540 μl of urine were analyzed following the addition of 60 μl of a d 2 O solution containing 5 mM TSP. The solutions were transferred to 5 mm NMR tubes. NMR spectra on the mouse urine samples were acquired on a Varian Inova 400 MHz using a 5-mm pulsed field gradient, inverse detection probe (Varian, Palo Alto, CA). The spectra were acquired with 1024 transients and a sweep width of 4650 Hz. The pulse sequence included a 4-s solvent pre-saturation period and a 2.6-s acquisition time. A 45°excitation pulse was used to provide quantitative results.
NMR metabolite identification. The data were processed using ACD software version 9 (Advanced Chemistry Development, Toronto, Canada). A 0.1-Hz exponential line broadening was applied to the data. The spectra were phased, baseline corrected and integrated using the ACD intelligent binning algorithm. The regions from 0.5 to 4.7 ppm and 4.9 to 9.0 were included in the integration. The regions below 0.5 and above 9.0 contained only noise and the region from 4.7 to 4.9 contained the residual solvent peak. The data were normalized by setting the sum of all integrals equal to 1000 for each spectrum. To account for the presence of alcohol and ethyl glucuronide in the samples from alcohol-treated mice, the spectra were renormalized after removal of the bins containing these peaks. Metabolite identification was made using the Chenomx NMR suite version 4.5 metabolite data base (Chenomx, Edmonton, Canada). Confirmation of assignments was aided by two-dimensional 1 H-13 C gHSQC and gHMBC experiments on selected samples.
ESI/FTICR-MS metabolite identification.
Raw mass spectra were initially batch processed using a custom VBA script within Bruker's DataAnalysis™ software to pick up monoisotopic ion peaks based on variable isotopic distribution patterns (Han et al., 2008) . The resulting monoisotopic mass lists together with their ion intensities and charge states from each spectrum were further processed with another custom software program (Han et al., 2008) written with LabView™ development software to do internal mass calibration with the mass calibration standards (haloperidol, verapamil, reserpine and a known endogenous metabolite, phosphocholine at m/z 184.0733). The ion intensity of each picked monoisotopic peaks on a spectrum were normalized to the total ion intensity of all the picked monoisotopic ion peaks. The resulting mass lists were then filtered to recognize sodium (+22.9892) and potassium (+38.9632) adduct ions and binned to a unique neutral mass. The total intensity from the protonated, sodiated, and potassiated ions of the same metabolite was summed up. Duplicate measurements of each sample were compared to verify correlation (i.e., to ensure that there were no instrumental problems affecting signal acquisition or instrument calibration during that particular run). Masses observed in the set of correlated replicates were combined into a single biological replicate by averaging intensities from masses that matched within a selectable mass accuracy (typically 2 ppm). Biological replicates from multiple animals were then aligned to yield a list of masses observed. Aligned mass lists from sets of control and alcohol-treated animals were then combined, keeping all mass values regardless of their occurrence across the set. For metabolite assignment, chemical molecular formulae incorporating unlimited number of C, H, N, O, and a maximum of two S, three P, one Na and one potassium) were generated based on accurate masses using the Generate Molecular Formula tool with DataAnalysis™ software. The Human Metabolome database (http:// www.hmdb.ca/) and Lipid Maps Database (www.lipidmaps.org/data/ structure/text_ search.php) were used to search potential matching metabolites consistent with the measured mass with 1 ppm.
Statistical analysis.
The statistical analyses on NMR data were performed using SimcaP+ v.11.5 software (Umetrics, Umea, Sweden). Pareto scaling was applied to the NMR integration data prior to principal component analysis and orthogonal partial least squares analysis. Markers of liver injury were assessed using Student's t-test.
Results

Modified Lieber-DeCarli diet produces steatohepatitis in mice
Feeding of a modified Lieber-DeCarli diet to mice for 28 days resulted in a significant elevation of blood alcohol content (Table 1) . Mice fed control corn oil-based high-fat diet exhibited no signs of liver damage (Fig. 1A) , or change in clinical chemistry parameters (Table 1) . Conversely, treatment with alcohol-containing corn oil-based high-fat modified Lieber-DeCarli liquid diet for 28 days caused fatty liver, inflammation and necrosis (Fig. 1B) , as well as significant elevation in enzyme markers of liver injury (Table 1) . Specifically, alcohol-fed mice developed substantial liver steatosis, as evidenced by the significant elevation in oil red O-positive fat deposits (Figs. 1C and D, Table 1 ). In addition, liver necrosis and inflammation were also observed in alcohol-treated mice as demonstrated by significant increases in necrosis, steatosis and total histology scores and a 5-fold elevation in serum activity of alanine aminotransferase (Table 1 ). In addition, alcohol feeding caused a significant decrease in liver glycogen content as measured by periodic acid-Schiff staining (Figs. 1E and F, Table 1) , and an increase in lipid peroxidation as evidenced by accumulation of 4-hydroxynonenal in liver parenchymal cells (Figs. 1G and H) . Urine was analyzed for creatinine and osmolarity (Table 1) . While alcohol feeding had no effect on creatinine levels, a significant increase in osmolarity, suggestive of dehydration, was observed. Collectively, these data establish that feeding corn oil-based high-fat Lieber-DeCarli liquid diet may serve as an acceptable alternative to the enteral feeding mouse model for studies on alcohol-induced liver injury as it produces a similar phenotype of steatohepatitis that is much more pronounced than with a standard Lieber-DeCarli protocol. Liver Liver/Body Ratio (%) 5.7 ± 0.5 5.5 ± 0.5 Total Histology Score 0.6 ± 0.2 4.1 ± 0.1 ⁎ Inflammation Score 0.5 ± 0.6 1.4 ± 0.8 Necrosis Score 0.1 ± 0.3 1.3 ± 0.6 ⁎ Steatosis Score 0 ± 0 1.5 ± 1.2 ⁎ Oil Red-O (fat, % area) 7.3 ± 3.6 22.9 ± 5.5 ⁎ Glycogen (PAS, % area) 17.5 ± 4.3 1.4 ± 0.6 ⁎ Serum ALT (U/l) 15.2 ± 3.9 74.3 ± 18.4 ⁎ Blood alcohol (mg/dl) 59.5 ± 2.4 281 ± 33 ⁎ GGT (U/l) 5 ± 0 5 ± 0 Urine Creatinine (mg/l) 18.0 ± 1.2 18.4 ± 0.5 Osmolarity (mOS) 366 ± 100 493 ± 37 ⁎
The data shown are mean ± standard error of the mean (n = 4). ⁎ Denote statistically significant difference (P b 0.05) from control group. 
Metabolomic analysis of alcohol-induced liver injury
Aqueous extracts of liver tissue and urine were analyzed by NMR to determine what changes in metabolome are associated with a deleterious effect of alcohol on liver. Fig. 2 shows representative chromatograms from the NMR-based analysis of the urine ( Figs. 2A and B) and liver (Figs. 2C and D) extracts. Orthogonal partial least squares model-based analysis of the data was performed to determine the metabolites responsible for the separation of the control and alcohol-treated groups. From these models, rank-ordered lists of the most influential spectral bins were generated. Table 2 lists the metabolites present in those bins along with their coefficients. The magnitude of the coefficient value is proportional to its influence on the separation and the sign indicates whether that metabolite is up (+) or down in alcohol-treated mice. Collectively, NMR analysis identified nine molecules in the aqueous phase of liver extracts and 11 molecules in the urine as significantly altered due to the alcohol treatment.
Principal component analysis of the NMR-derived metabolomic data shows a clear separation between control and alcohol treatments in both urine samples (Fig. 3A) and liver extracts (Fig. 3B) , even though alcohol and ethyl glucuronide peaks were removed from this analysis. The first principal component accounted for over 90% of the variation in the data for both the urine and liver extracts. No time-related differences in the urine metabolome were evident between samples collected from mice after 22, 30, or 36 days of alcohol feeding (data not shown). In the liver, no differences were observed between high fatcontaining diet fed mice and a naïve mouse, but alcohol treatment produced a clear divergence in the metabolite profiles.
Additional analysis of the metabolites present in the organic phase of the liver metabolite extracts from control and alcoholtreated mice was performed using ESI/FTICR-MS in positive ion mode. Internal standards were employed for mass calibration and to facilitate metabolite identification based on accurate metabolite masses within b1 ppm. More than 300 metabolite features were reproducibly detected between samples within either control or alcohol groups at a signal to noise ratio above 3. Fig. 4 shows a representative 280 to 330 m/z window from the analysis (from a full range of 100 to 1000 m/z) of high-fat control (Fig. 4A ) and alcoholtreated (Fig. 4B ) liver samples. High overall reproducibility between samples is evidenced by the fact that individual peaks are superimposed between spectra from the biological replicates within each group. A zoom-in view of the 309.22 to 309.32 m/z range (Fig. 4C) shows an example of several metabolites that exhibit a difference in abundance between treatments. The representative peak identified as 11,14-eicosandienoic acid, a prostaglandin H endoperoxide synthase substrate (Koshkin and Dunford, 1998) , is increased as a result of sub-chronic treatment with alcohol.
To identify the metabolites identified as changing in response to sub-chronic administration of alcohol, the Human Metabolome Spectra from the alcohol-treated mice are annotated with assignments of some of the metabolites present. EthylGluc, ethylglucuronide; EtOH, alcohol; Lac, lactate; Ac, acetate; NAcGly, N-acetylglycine; NAcGlu, N-acetylglutamine; TMA, trimethylamine; Crtnn, creatinine; Crtn, creatine; Tau, taurine; Tart, tartrate; Lact, lactose; Malt, maltose; Carn, carnitine; Actn, acetone; Ala, alanine; Leu, Leucine; ILeu, isoleucine; Val, valine. database and Metlin metabolome database were queried after the molecular formulae (incorporating the designated numbers of C, H, N, O, S, P, Na and K) for each peak were generated based on measured mass within 1 ppm accuracy. Table 3 lists 14 metabolites (b600 Da) identified through this process (in some cases, more than one likely candidate molecules were assigned due to structural isomers of their completely identical masses).
Discussion
Rodent models of alcohol induced liver injury: state-of-the-art and current gaps
Establishment of a compelling and human-relevant model of alcohol-induced liver injury in rodents has been difficult for a number of reasons, especially since the metabolic rates vary dramatically among species. Two major routes taken by the investigators in this field have been a survival surgery-requiring intragastric model (Tsukamoto et al., 1984) , and a liquid diet-based voluntary feeding model (Lieber and DeCarli, 1982) . The ability to reproduce the phenotypic hallmarks of alcohol-induced liver disease in humans, at least steatosis, inflammation, and necrosis, is usually used as a benchmark for the model's success. Significantly, this report details a straightforward approach to achieve appreciable alcohol-induced liver injury in the mouse without surgery or continuous force-feeding of alcohol.
Many attempts to induce liver injury in the mouse by feeding liquid diets have not succeeded in inducing hepatitis in addition to fatty liver. When a low-fat (10%) formulation of the Lieber-DeCarli liquid diet containing cocoa butter and safflower oil was fed to mice for 4 weeks, an increase in serum fatty acids, triglycerides and products of ketogenesis, along with histological changes in steatosis, were observed (Fischer et al., 2003) . Similarly, when alcohol dehydrogenase-positive and -negative deer mice were fed a high mixed fat (35%; olive, safflower and corn oil) Lieber-DeCarli diet for 8.5 weeks, no statistically significant elevation in serum ALT levels or steatosis in alcohol dehydrogenase-positive deer mice was observed even though ALT levels were increased 2-fold in alcohol dehydrogenase-negative deer mice (Bhopale et al., 2006) . A recent study which examined the role of methionine and choline deficiency in alcoholinduced liver disease reported that liver injury was observed after 6 weeks of feeding, but only with a modified Lieber-DeCarli formulation deficient in methionine and choline (Gyamfi et al., 2008) . In female C57Bl/6J mice fed with a low-fat formulation of Lieber-DeCarli diet (12%; olive, safflower and corn oil) for about 7 weeks, an increase in serum markers of liver injury and advanced degree of steatosis, but not an increase in inflammation and necrosis, were observed .
Our study achieved blood alcohol levels at euthanization nearly as high as those observed previously in the liquid diet feeding studies; however, liver injury was much greater and achieved sooner than previously reported in the literature. Both liver pathology scores and serum enzyme levels were significantly elevated and were nearly identical to those reported when C57Bl/6J mice were fed corn oilbased diet intragastrically (Kono et al., 2000) . Thus, we argue that the use of corn oil as the source of fat in Lieber-DeCarli formulations, similar to the previous reports on feeding high corn oil-based alcoholcontaining diets to rats (Enomoto et al., 1999) , or to the data from the intragastric model (Nanji et al., 1989) , is the main contributing factor which greatly facilitates liver injury due to alcohol.
Metabolomic analyses delineate alcohol-induced changes in liver metabolism
Effects on energy supply
Although metabolic markers in liver are not routinely available from humans, the animal model used in this study offers the opportunity to assess biochemical perturbations that affect rates of metabolism due to ingestion of alcohol. It has been well documented that both short-and long-term alcohol treatments cause acceleration (i.e., adaptive increase) of rates of alcohol metabolism in vivo in the rat (Bleyman and Thurman, 1979) . In the mouse, it has been reported that short-term (4 h) exposure to vaporous alcohol can also cause a significant increase in liver metabolism ; however, limited work has been conducted to assess the effects of long-term exposures to alcohol on rates of metabolism. In addition, basal metabolism in the mouse is much higher than in the rat or humans and these differences have not been fully characterized in vivo.
Treatment with alcohol is known to stimulate liver metabolism and increase oxygen uptake leading to hypoxia in the pericentral regions in the liver lobule (Ji et al., 1982) . The data from our study point to two possible explanations. One metabolite found in this study, N-oleoylethanolamine, has been reported to enhance hypoxic liver injury in an ischemia reperfusion model in mice (Llacuna et al., 2006) . N-oleoylethanolamine was elevated 2.6-fold after alcohol treatment and, because it is an inhibitor of ceramide metabolism thus causing high levels of ceramide and enhancing hypoxic injury, it is a very supportive piece of evidence to demonstrate metabolic links with pathological changes in liver after sub-chronic alcohol exposure. Additionally, it has been suggested that high blood levels of lactic acid correlate with hypoxia (Bakker, 1999) . We also observed that lactate in liver and urine was high in alcohol-fed mice, which is consistent with data from the enteral model which demonstrated high levels of Fig. 3 . Principal components analysis of the 1 H NMR spectra from (A) urine (n = 4, samples were collected on days 22, 30 and 36); and (B) liver (n = 3 for high-fat control and alcohol, samples were collected on day 28). Each point represents and individual measurement. In the urine spectra, alcohol and its main metabolite, ethyl-glucuronide, were removed from the analysis.
hypoxia after chronic alcohol feeding (Arteel et al., 1997) . High oxygen demand in liver parenchymal cells translates into stimulation of mitochondrial function and rapid cofactor turnover, factors which exacerbate pericentral hypoxia. Similar to previous reports in the rat, our data in the mouse show that alcohol causes depletion in liver glycogen stores and stimulates glycolysis. Indeed, lower levels of glucose in liver of alcohol-fed mice are likely the net result of prolonged activation of glycolysis and lack of activation of gluconeogenesis. Alanine and leucine were found to be elevated in liver which is consistent with postulated alterations in glycolysis by alcohol. Furthermore, both alcohol dehydrogenase and lactate dehydrogenase require NAD+ and competition for this cofactor may also help to explain why lactate is high after alcohol feeding. The effects of alcohol on precursors of the TCA cycle have been characterized using the isolated perfused rat liver in the presence and absence of the added fatty acid oleate (Williamson et al., 1969) . In those studies, alcohol and oleate caused an inhibition of gluconeogenesis which is consistent with our observations. Alcohol metabolism can slow TCA cycle significantly when fatty acids are available (Williamson et al., 1969) , and our data show that similar pathways operate in the mouse. Specifically, threonine, a precursor for valine which can be metabolized to a citric acid cycle precursor succinyl CoA, was elevated in urine and liver in alcohol-treated mice. Acetate levels were also high in liver, which suggests a decrease in its metabolism to acetyl-CoA. Build up of these TCA cycle precursors demonstrates that energy status of the liver is lowered following alcohol treatment. Furthermore, in a recent study that used NMR to analyze liver extracts from rats given alcohol acutely or as a binge, it was found that hepatic glucose decreased even though acetate was increased (Nicholas et al., 2008) . While these observations are similar to our findings, a decrease in alanine and lactate in both acute and binge models was reported. This is in contrast to our observations in the model of sub-chronic feeding of alcohol. We argue that a high fat diet used in the sub-chronic study is the reason for these differences, since an increased supply of fatty acids may impact energy demand. This notion is supported by the fact that fatty acids reduce the supply of acetyl-CoA to the citric acid cycle (Williamson et al., 1969) . Thus, we conclude that sub-chronic treatment with alcohol and high-fat diet, conditions reflective of the human consumption, produces a very unique signature that could be differentiated from acute or binge models.
Fatty acid metabolism
In a model of isolated perfused rat liver, acute alcohol treatment has been shown to result in increased ketogenesis (Yuki and Thurman, 1980) . In addition, lipid peroxidation, as measured by accumulation of 4-hydroxynonenal protein adducts, is known to be elevated in liver after enteral alcohol feeding in the rat (Arteel et al., 2002) . Our study shows a comparable increase in lipid peroxidation in mouse liver after 28 days of alcohol feeding. This observation, together with low glucose levels detected by both NMR and FTICR-MS and elevated isoleucine and leucine found in alcohol-fed mice, suggests an increase in ketogenesis. Additionally, carnitine, which is not an essential nutrient but participates in transport of long-chain fatty acids from the cytosol into the mitochondria and participates in β-oxidation, was higher in liver after alcohol treatment. It is known that carnitine is metabolized to β-methyl choline and eventually to threonine which was elevated in urine after alcohol (Mitchell, 1978) .
Sub-chronic treatment with alcohol causes liver inflammation as was demonstrated here and in the enteral model of alcohol-induced liver injury. Products of arachidonic acid metabolism through cyclooxygenase and lipoxygenase, such as prostaglandins, prostacyclins, thromboxanes and leukotrienes, are thought to be key mediators of alcoholic steatohepatitis. Indeed, thromboxane B2 and leukotriene B4 are elevated following alcohol treatment when a high-fat corn oil diet is used in the enteral alcohol feeding model (Nanji et al., 1994) . Acute treatment with alcohol also has been shown to increase production of prostaglandin E2 in isolated rat Kupffer cells (Enomoto et al., 2000) . In this study, linoleic acid, an essential fatty acid and a precursor of prostaglandins via arachidonic acid, was elevated in liver following sub-chronic alcohol treatment. Arachidonate was lower after alcohol, which may be due to increased utilization under these conditions. In addition, our data show that alcohol feeding caused a 2.8-fold increase in liver 7,10,13,16-docosatetraenoic acid, an arachidonate metabolite and a potent prostacyclin inhibitor (Mann et al., 1986 ) and a decrease in the prostacyclin metabolite 2,3-dinor-6-ketoprostaglandin F1α. Prostacyclins are important for regulation of platelet formation and blood clotting. In fact, 11,14-eicosadienoic acid, a substrate for prostaglandin synthetase, was elevated after alcohol which is consistent with slowed production of prostaglandin G2 and H2 and, ultimately, prostacyclins. Inhibition of platelet aggregation by an inhibitor such as 7,10,13,16-docosatetraenoic acid, and a decrease in eicosenoic acid, a marker for membrane stability in red cells, could potentially explain why chronic drinking can cause bleeding problems in humans (Schoenfeld et al., 2007) .
Metabolomic biomarkers of alcohol-induced liver injury
Since the animal model of alcohol-induced liver injury developed in this study mimics human disease, we were interested in what parallels can be drawn between species. In support of the human relevance of this mouse model, important similarities were observed. It is well known that ethyl glucuronide is a marker of alcohol ingestion in both humans (Wurst et al., 1999) and rats (Nicholas et al., 2006) . Similarly, we found that ethyl glucuronide is markedly increased in alcohol-fed mice. Although alcohol metabolism via glucuronidation is a very minor pathway of alcohol metabolism, the half-life of this molecule in the urine in quite long and it is detectable well after alcohol cannot be measured in blood (Droenner et al., 2002) .
Furthermore, in a study of 186 males categorized as drinkers and smokers (Simon et al., 1996) , it was shown that alcohol drinking was associated with higher levels of palmitic, myristic, palmitoleic, oleic, and adrenic fatty acids in serum. Similar changes in liver fatty acid profiles were observed in our mouse study. Importantly, in the human study, serum levels of stearic acid were low when less than 30 drinks per week were consumed, but increased significantly with heavy drinking. Thus, elevated levels of stearic acid found in the mouse may suggest that the dose of alcohol in these animal experiments was equivalent to the human consumption of more than 30 drinks per week. However, while in human alcohol abusers the levels of linoleic acid in serum were low, we found an increase in liver linoleic acid in alcohol-fed mice. These conflicting data could be due to the differences in dietary content of fat, transient levels of fatty acids in serum versus liver in these two studies, or reflect varying rates of metabolism between species.
We also observed that alcohol treatment caused a significantly higher level of urinary n-acetylglutamine and n-acetylglycine. In humans, elevation of these molecules in urine has also been reported and linked to renal tubular injury after antibiotic treatment (Racine et al., 2004) , or a mutation in the aminoacylase I (EC3.5.1.14, a renal cortex enzyme which hydrolyses N-acetylated amino acids) gene (Gerlo et al., 2006) . Our observations may suggest that alcohol treatment may inhibit aminoacylase I and that urinary n-acetylglutamine and n-acetylglycine could be considered as potential noninvasive biomarkers for alcohol consumption.
There is much in the literature to suggest that antioxidant pathways are activated to help protect the body when challenged by chronic exposure to chemicals. Because alcohol exposure causes oxidative stress, it is known that glutathione plays a key protective role. In this study, taurine which is synthesized from methionine and is a metabolite of glutathione pathway was lower after alcohol treatment, similar to the data reported by Shin and Linkswiler (1974) . Thus, we argue that urinary taurine may be also used as a marker of oxidative stress.
It should be noted that some of the metabolites found in this study to be changed are not unique to alcohol or high-fat diet exposure. In a recent review of metabolomic data from liver and other organs after toxic chemical exposures, it was argued that several metabolite biomarkers are hallmarks of liver injury, rather than a particular treatment (London and Houck, 2004) . For example, most toxicity studies report an elevation in acetate levels in liver which is in agreement with our study. Although acetate is a metabolite of alcohol, it is also produced from glycerolphospholipid and pyruvate metabolism.
In summary, this study details a mouse model for early alcoholinduced liver disease which produces liver injury consistent with pathological changes seen in human patients. The metabolomic data obtained in this study provide new important mechanistic clues about the effects of alcohol and high-fat corn oil-based diet on liver metabolism and energy utilization which may be important for understanding the pathogenesis of liver injury. We propose that several of the molecules, such as urinary levels of n-acetylglutamine, n-acetylglycine and taurine, could be used as novel non-invasive markers of alcohol consumption and oxidative stress. While further work will be necessary to determine if these biomarkers correlate with liver injury in humans, this mouse model can aid in preclinical studies.
